Game On: Topokine Initiates Late-Stage Trial of XAF5 Ointment for Reining in Undereye Bags
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
Topokine Therapeutics initiated a Phase 2b/3 trial for XAF5 Ointment for the reduction of undereye bags.
BTL’s Emsculpt Neo has received FDA clearance to stimulate neuromuscular tissue in the legs and arms for rehabilitation, expanding its original use for fat reduction and muscle building to now address medical conditions and improve patients’ mobility and recovery.
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Researchers from Florida Atlantic University have received a four-year, $1.2 million grant from the National Science Foundation to empower amputees to maximize their individual potential for controlling the full dexterity of artificial hands.
Advalight, which offers the ADVATx dermatology laser, announces that Beverly Hills, Calif.-based, board-certified plastic surgeon Daniel Barrett, MD, is now providing its non-ablative laser treatments.
APONVIE, from Heron Therapeutics, is an injectable emulsion for IV use in adults for the prevention of postoperative nausea and vomiting.